Literature DB >> 11926409

HLA class I antigen abnormalities and immune escape by malignant cells.

Barbara Seliger1, Teresa Cabrera, Federico Garrido, Soldano Ferrone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11926409     DOI： 10.1006/scbi.2001.0404

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN： 1044-579X            Impact factor:   15.707


× No keyword cloud information.
  64 in total

1.  Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5.

Authors:  Hae-Wan Lee; Soo Kee Min; Young-Su Ju; Joohon Sung; Man Sup Lim; Dae Hyun Yang; Bong Hwa Lee
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

2.  Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.

Authors:  Sourabh Ghosh; Rachel Rosenthal; Paul Zajac; Walter P Weber; Daniel Oertli; Michael Heberer; Ivan Martin; Giulio C Spagnoli; Anca Reschner
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Cloning and functional analyses of the mouse tapasin promoter.

Authors:  Felix Herrmann; John Trowsdale; Christoph Huber; Barbara Seliger
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

4.  Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma.

Authors:  Sulai Liu; Lin Qi; Qiuxia Yu; Yinghui Song; Weiqing Han; Xiongbing Zu; Shusuan Jiang; Jinyang Yuan; Fuhua Zeng; Yu Xie
Journal:  Tumour Biol       Date:  2014-05-23

5.  Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.

Authors:  Christopher E Touloukian; Wolfgang W Leitner; Paul F Robbins; Yong F Li; Xiaoqiang Kang; Rejean Lapointe; Patrick Hwu; Steven A Rosenberg; Nicholas P Restifo
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

6.  Reduced expression of members of the mhc-i antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China.

Authors:  A Haimiti; Y Hailiman; A Gulina; J Du; Z Hao; X L Rong; A Zainuer; W Qin; S Lalai
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

7.  Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.

Authors:  Andreas E Albers; Carsten Schaefer; Carmen Visus; William Gooding; Albert B DeLeo; Theresa L Whiteside
Journal:  Head Neck       Date:  2009-06       Impact factor: 3.147

8.  HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Authors:  María A Garrido; Teresa Rodriguez; Svitlana Zinchenko; Isabel Maleno; Francisco Ruiz-Cabello; Ángel Concha; Nicolás Olea; Federico Garrido; Natalia Aptsiauri
Journal:  Immunogenetics       Date:  2018-08-25       Impact factor: 2.846

9.  Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.

Authors:  Paolo Carrega; Gaetana Pezzino; Paola Queirolo; Irene Bonaccorsi; Michela Falco; Giuseppe Vita; Daniela Pende; Aldo Misefari; Alessandro Moretta; Maria Cristina Mingari; Lorenzo Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

10.  Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation.

Authors:  Juliane S Stickel; Natalie Stickel; Jörg Hennenlotter; Karin Klingel; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Journal:  BMC Urol       Date:  2011-01-20       Impact factor: 2.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.